Literature DB >> 1799940

Studies on antiulcer drugs. I. Synthesis and antiulcer activities of imidazo[1,2-alpha]pyridinyl-2-oxobenzoxazolidines-3-oxo-2H-1,4-benzoxaz ines and related compounds.

Y Katsura1, S Nishino, H Takasugi.   

Abstract

A series of imidazo[1,2-alpha]pyridinyl-2-oxobenzoxazolidines (4a-i), -3-oxo-2H-1,4-benzoxazines (5a-q), their thio-analogues (4j-p and 5r-t) and 5,6,7,8-tetrahydroimidazo[1,2-alpha]pyridinyl derivatives (8 and 9) were synthesized and tested for anti-stress ulcer activity in rats. Several compounds were found to be more active than the reference compounds, zolimidine, cimetidine and sucralfate. Among them, compound 4e, 5i and 5l also exhibited potent protective activity against ethanol-induced gastric lesion. The synthesis and structure-activity relationships of these compounds are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1799940     DOI: 10.1248/cpb.39.2937

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

1.  One-pot solvent-free synthesis of 2,3-dihydro-2-substituted-1H-naphtho[1,2-e][1,3]oxazine derivatives using Fe3O4@nano-cellulose/TiCl as a bio-based and recyclable magnetic nano-catalyst.

Authors:  Sara Azad; Bi Bi Fatemeh Mirjalili
Journal:  Mol Divers       Date:  2018-10-12       Impact factor: 2.943

2.  Synthesis and anticancer activity of bis(2-arylimidazo[1,2-a]pyridin-3-yl) selenides and diselenides: the copper-catalyzed tandem C-H selenation of 2-arylimidazo[1,2-a]pyridine with selenium.

Authors:  Mio Matsumura; Tsutomu Takahashi; Hikari Yamauchi; Shunsuke Sakuma; Yukako Hayashi; Tadashi Hyodo; Tohru Obata; Kentaro Yamaguchi; Yasuyuki Fujiwara; Shuji Yasuike
Journal:  Beilstein J Org Chem       Date:  2020-05-20       Impact factor: 2.883

3.  Gum arabic-OPO3H2 as a new natural-based green catalyst for the one-pot pseudo-four-component synthesis of naphtho[1,2-e][1,3]oxazines.

Authors:  Sahar Saadat Hosseinikhah; Bi Bi Fatemeh Mirjalili; Naeimeh Salehi; Abdolahamid Bamoniri
Journal:  RSC Adv       Date:  2020-11-06       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.